The global positive airway pressure devices market size was valued at USD 3.62 billion in 2021. It is projected to reach USD 6.29 billion by 2030, growing at a CAGR of 6.08% during the forecast period (2022–2030).
In the positive airway pressure procedure, the air is pumped into the lungs' airways while pressure is applied. This treatment effectively keeps patients' windpipes open while they sleep. Continuous positive airway pressure can help people with breathing problems such as obstructive sleep apnea by preventing their airways from collapsing. It is incredibly safe to use and works for people of all ages, including children.
Regular use of a CPAP (Continuous Positive Air Pressure) machine has several benefits, including improved concentration and memory, better sleep for the user's bed partner, fewer feelings of anxiety and depression, improved mood, increased productivity at work, and normalized sleep patterns.
|Market Size||USD 6.29 billion|
|Fastest Growing Market||Asia Pacific|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
A significant economic burden caused by sleep apnea is a major factor driving the growth of the global positive airway pressure devices market. Sleep apnea is associated with various health problems, such as diabetes, hypertension, heart disease, and depression, increasing the financial burden on patients.
Furthermore, untreated sleep apnea can lead to workplace accidents and decreased productivity. Sleep apnea is insomnia caused by various factors such as specific diseases, financial stress, and other personal concerns. Demand for positive airway pressure devices is anticipated to increase due to governments' supportive initiatives to offer effective treatment to those suffering from sleep apnea. Positive airway pressure device manufacturers are innovating and upgrading existing products to improve compliance rates.
Positive air pressure device efficiency has been steadily increasing due to recent advancements in positive airway pressure technology, increasing the percentage of satisfied patients. All of these factors are expected to drive demand for positive airway pressure devices in the global positive airway pressure devices market throughout the forecast period. Positive air pressure therapy is more likely accepted by patients diagnosed with sleep apnea.
The continuous positive airway pressure devices industry might not be able to expand as quickly as it might due to a few different factors. One of the most significant of these is the exorbitant price tag attached to the CPAP machines, which are frequently out of many people's price range. In addition, the patients may experience adverse effects due to the utilization of these devices. As a result, the growth of the CPAP devices market may be hampered in the long run by these factors.
The development of smart positive airway pressure devices presents established and emerging players in the healthcare industry with a unique opportunity. This is due to the growing emphasis on remote patient monitoring, mobile health applications, and the incorporation of telemedicine into the treatment and diagnostic aspects of healthcare. Patients could track their quality of breathing, sleep, and adherence to therapy if PAP device manufacturers create products that can be integrated with a mobile application. In addition, the mobile application may facilitate sharing patient monitoring information with a physician.
The global positive airway pressure devices market is segmented into different regions, namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Positive airway pressure devices have the largest market in Europe. Developing countries like Asia-Pacific are expected to see rapid growth in the adoption of these devices shortly.
Based on product type, the market is segmented into Automatic Positive Airway Pressure (APAP) Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Bi-level Positive Airway Pressure (BiPAP) Devices.
The market share of Continuous Positive Airway Pressure (CPAP) devices is expected to increase significantly during the forecast period. Patients who snore and have episodes of obstructed breathing while sleeping are frequently given CPAP, the first-line treatment for obstructive sleep apnea. In addition, increased adoption of these devices due to their low-cost relative to other positive airway pressure devices has contributed to the expansion of this market segment.
Based on end-user, the market is segmented into Hospitals and Sleep Labs, Home Care, and Others.
The hospitals and sleep labs segment is dominating the market. Sleep studies are typically conducted in sleep laboratories to monitor physiological data such as heart rate, respiration, and oxygen levels to diagnose sleeping disorders. Post-pandemic sleep laboratory demand is anticipated to return to normal as patients with severe OSA requiring in-clinic monitoring continue to visit sleep laboratories.